Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies-Reference-Cited by-同舟云学术

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies

Published:2023-04-18 Issue:5 Volume:6 Page:710-726
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Zhang Yu¹^ORCID,Popel Aleksander S.¹,Bazzazi Hojjat¹^ORCID

Affiliation:

1. Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

Funder

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00008

Reference105 articles.

1. Hallmarks of Cancer: The Next Generation

2. Tumor Angiogenesis: Therapeutic Implications

3. Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

4. Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results

5. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. bnglViz: online visualization of rule-based models;Bioinformatics;2024-05-30

2. Endothelial cells signaling and patterning under hypoxia: a mechanistic integrative computational model including the Notch-Dll4 pathway;Frontiers in Physiology;2024-02-22

3. Advancements in the ERK1/2 Signaling Pathway Affecting Male Reproduction;Frontiers in Bioscience-Landmark;2024-01-18

4. The potential of monoclonal antibodies for colorectal cancer therapy;Medical Oncology;2023-08-21